ArticleAnesthesia and pain medicine2026
Accidental epidural administration of sugammadex and ramosetron - A case report.
Article in Anesthesia and pain medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWrong-route administration of intravenous (IV) medications into the epidural space is a rare but potentially harmful event in anesthetic practice. Although various agents have been inadvertently injected via the epidural route, there have been no previous reports involving sugammadex or ramosetron. CASE: We report the accidental epidural injection of sugammadex (200 mg) and ramosetron (0.3 mg) in a 69-year-old female under general anesthesia with thoracic epidural analgesia. Errors were recognized within 5 min. As the patient exhibited no immediate adverse effects, emergence from anesthesia proceeded with IV sugammadex administration. Six hours later, the patient developed mild right triceps weakness and bilateral C8 dermatomal tingling, which improved on postoperative day two. The patient was discharged without any neurological sequelae.
conclusionsAlthough the outcome was benign, this incident underscores the potential risks of wrong-route drug delivery and highlights the need for vigilance and preventive strategies in perioperative medication management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.